UtilisingGalleria mellonella larvae for studying in vivo activity of conventional and novel antimicrobial agents

25Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The immune response of insects displays many structural and functional similarities to the innate immune response of mammals. As a result of these conserved features, insects may be used for evaluating microbial virulence or for testing the in vivo efficacy and toxicity of antimicrobial compounds and results show strong similarities to those from mammals. Galleria mellonella larvae are widely used in this capacity and have the advantage of being easy to use, inexpensive to purchase and house, and being free from the ethical and legal restrictions that relate to the use of mammals in these tests. Galleria mellonella larvae may be used to assess the in vivo toxicity and efficacy of novel antimicrobial compounds. A wide range of antibacterial and antifungal therapies have been evaluated in G. mellonella larvae and results have informed subsequent experiments in mammals. While insect larvae are a convenient and reproducible model to use, care must be taken in their use to ensure accuracy of results. The objective of this review is to provide a comprehensive account of the use of G. mellonella larvae for assessing the in vivo toxicity and efficacy of a wide range of antibacterial and antifungal agents.

Cite

CITATION STYLE

APA

Piatek, M., Sheehan, G., & Kavanagh, K. (2020, November 1). UtilisingGalleria mellonella larvae for studying in vivo activity of conventional and novel antimicrobial agents. Pathogens and Disease. Oxford University Press. https://doi.org/10.1093/femspd/ftaa059

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free